カテゴリ： MarketLine, ノルウェー, 企業調査

SpareBank 1 Nord-Norge：企業の戦略・SWOT・財務分析

◆英語タイトル：SpareBank 1 Nord-Norge - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY4025
◆発行会社（調査会社）：MarketLine
◆発行日：2019年12月
◆ページ数：31
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：ノルウェー
◆産業分野：Financial Services
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

SpareBank 1 Nord-Norge – Strategy, SWOT and Corporate Finance Report
Summary

SpareBank 1 Nord-Norge – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

SpareBank 1 Nord-Norge (SpareBank) offers a wide range of retail and corporate banking and related financial solutions. Its offerings include loans for mortgage, construction, consumer needs, and automobile; bank savings accounts, pension savings accounts; stocks and mutual funds; credit and debit cards. The bank offers insurance solutions for life, vehicle, boat, property, savings and pension plan, disability, child, health, construction, transportation, group accident, liability, machinery, and fire-related damages. SpareBank’s service portfolio includes overdrafts, leasing and factoring, online banking, mobile banking, and payment services, among others. SpareBank is headquartered in Tromso, Norway.

Scope

- Detailed information on SpareBank 1 Nord-Norge required for business and competitor intelligence needs
- A study of the major internal and external factors affecting SpareBank 1 Nord-Norge in the form of a SWOT analysis
- An in-depth view of the business model of SpareBank 1 Nord-Norge including a breakdown and examination of key business segments
- Intelligence on SpareBank 1 Nord-Norge’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about SpareBank 1 Nord-Norge, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of SpareBank 1 Nord-Norge and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess SpareBank 1 Nord-Norge as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on SpareBank 1 Nord-Norge’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
SpareBank 1 Nord-Norge: Company Overview
SpareBank 1 Nord-Norge: Overview and Key Facts
SpareBank 1 Nord-Norge: Overview
SpareBank 1 Nord-Norge: Key Facts
SpareBank 1 Nord-Norge: Key Employees
SpareBank 1 Nord-Norge: Key Employee Biographies
SpareBank 1 Nord-Norge: Major Products and Services
SpareBank 1 Nord-Norge: Company History
SpareBank 1 Nord-Norge: Management Statement
SpareBank 1 Nord-Norge: Locations and Subsidiaries
SpareBank 1 Nord-Norge: Key Competitors
SpareBank 1 Nord-Norge: Company Analysis
SpareBank 1 Nord-Norge: Business Description
SpareBank 1 Nord-Norge: SWOT Analysis
SpareBank 1 Nord-Norge: SWOT Overview
SpareBank 1 Nord-Norge: Strengths
SpareBank 1 Nord-Norge: Weaknesses
SpareBank 1 Nord-Norge: Opportunities
SpareBank 1 Nord-Norge: Threats
SpareBank 1 Nord-Norge: Corporate Financial Deals Activity
SpareBank 1 Nord-Norge: Financial Deals Overview
SpareBank 1 Nord-Norge: Top Deals 2015 – 2019YTD*
SpareBank 1 Nord-Norge: Capital Raising
SpareBank 1 Nord-Norge: Divestments
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: SpareBank 1 Nord-Norge: Key Facts
Table 2: SpareBank 1 Nord-Norge: Key Employees
Table 3: SpareBank 1 Nord-Norge: Company History
Table 4: SpareBank 1 Nord-Norge: Locations and Subsidiaries
Table 5: SpareBank 1 Nord-Norge: Key Competitors
Table 6: SpareBank 1 Nord-Norge: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 7: SpareBank 1 Nord-Norge: Top Deals 2015 - 2019YTD*
Table 8: SpareBank 1 Nord-Norge: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Table 9: SpareBank 1 Nord-Norge: Capital Raising by Deal Type (2015 - YTD*2019)
Table 10: SpareBank 1 Nord-Norge: Divestments Volume and Value Trend (2015 - YTD*2019)
Table 11: SpareBank 1 Nord-Norge: Divestments by Geography (2015 - YTD*2019)

★海外企業調査レポート[SpareBank 1 Nord-Norge：企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Oando Plc (OANDO)：石油・ガス：M&Aディール及び事業提携情報
    Summary Oando Plc (Oando) is a provider of integrated energy solutions to the oil and gas industry. Through its subsidiaries, the company explores for and produces oil and gas through the acquisition of rights in oil blocks on the Nigerian continental shelf and deep offshore. It has producing, devel …
  • GfK SE：企業の戦略・SWOT・財務情報
    GfK SE - Strategy, SWOT and Corporate Finance Report Summary GfK SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Galena Biopharma Inc (GALE)-医療機器分野：企業M&A・提携分析
    Summary Galena Biopharma Inc (Galena) is a biopharmaceutical company that develops and markets therapies for the treatment of unmet medical needs and advance care. The company's pipeline products comprise NeuVax, NeuVax Present, NeuVax Hercepti, NeuVax Vadis, GALE-401 and GALE-301 folate binding pro …
  • Thar Pharmaceuticals Inc-製薬・医療分野：企業M&A・提携分析
    Summary Thar Pharmaceuticals Inc (Thar Pharma), a subsidiary of Grunenthal GmbH is a healthcare solution provider that concentrates on transforming intravenous (IV) drugs into oral drugs for existing and new indications. The company’s lead product T121, an oral form of IV only zoledronic acid, is de …
  • Dana Brevini Spa
    Dana Brevini Spa - Strategy, SWOT and Corporate Finance Report Summary Dana Brevini Spa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • UTStarcom Holdings Corp. (UTSI)：企業の財務・戦略的SWOT分析
    UTStarcom Holdings Corp. (UTSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • 84 Lumber Co：戦略・SWOT・企業財務分析
    84 Lumber Co - Strategy, SWOT and Corporate Finance Report Summary 84 Lumber Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Cre8tek Ltd (FGO)：石油・ガス：M&Aディール及び事業提携情報
    Summary Cre8tek Ltd (Cre8tek), formerly Marion Energy Ltd, is an oil and gas exploration and production company. The company explores, acquires, develops, produces and markets oil and gas. It has core operations in Clear Creek field located in the Uinta Basin. Cre8tek also holds interest in the addi …
  • Biosearch Technologies Inc：医療機器：M&Aディール及び事業提携情報
    Summary Biosearch Technologies Inc (Biosearch), a subsidiary of LGC Ltd is a biotechnology company that designs and manufactures regents. The company develops, and manufactures custom oligonucleotide-based tools. Its products include valupanel reagents, fluorogenic probes and primers, stellaries RNA …
  • GV Gold：企業の戦略・SWOT・財務情報
    GV Gold - Strategy, SWOT and Corporate Finance Report Summary GV Gold - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Cellectis SA (ALCLS)：企業の財務・戦略的SWOT分析
    Summary Cellectis SA (Cellectis) is a clinical-stage biopharmaceutical company that research, develop and commercialise rational genome engineering technologies. The company pioneers gene editing company, deploying core proprietary technologies to develop off-the-shelf immunotherapies to target and …
  • ALS Ltd (ALQ)：企業の財務・戦略的SWOT分析
    ALS Ltd (ALQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • IRB Infrastructure Developers Ltd：企業の戦略・SWOT・財務情報
    IRB Infrastructure Developers Ltd - Strategy, SWOT and Corporate Finance Report Summary IRB Infrastructure Developers Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • PV Crystalox Solar plc (PVCS)：企業の財務・戦略的SWOT分析
    PV Crystalox Solar plc (PVCS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Recurrent Energy LLC：電力：M&Aディール及び事業提携情報
    Summary Recurrent Energy LLC (Recurrent Energy), a subsidiary of Canadian Solar Inc. is a mainstream clean energy company that operates a portfolio of solar energy projects and generates electricity. The company develops and operates a portfolio of utility scale power projects. It has more than 4 GW …
  • Seagen Inc (SGEN)：企業の財務・戦略的SWOT分析
    Seagen Inc (SGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Brunel International NV (BRNL)：企業の財務・戦略的SWOT分析
    Brunel International NV (BRNL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Porcelanosa Grupo AIE：企業の戦略・SWOT・財務情報
    Porcelanosa Grupo AIE - Strategy, SWOT and Corporate Finance Report Summary Porcelanosa Grupo AIE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Waters Corporation：企業の戦略・SWOT・財務情報
    Waters Corporation - Strategy, SWOT and Corporate Finance Report Summary Waters Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Huadian Power International Corporation Ltd (1071)：電力：M&Aディール及び事業提携情報
    Summary Huadian Power International Corporation Ltd (HPICL) is an electric utility. It constructs and operates power plants, including coal- or gas-fired generating units and renewable energy projects. The company has plants at the electricity and heat load centers or regions with abundant coal reso …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆